Literature DB >> 19412552

Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria.

John D Young1, Jan Martel, David Young, Andrew Young, Chin-Ming Hung, Lena Young, Ying-Jie Chao, James Young, Cheng-Yeu Wu.   

Abstract

Calcium and apatite granulations are demonstrated here to form in both human and fetal bovine serum in response to the simple addition of either calcium or phosphate, or a combination of both. These granulations are shown to represent precipitating complexes of protein and hydroxyapatite (HAP) that display marked pleomorphism, appearing as round, laminated particles, spindles, and films. These same complexes can be found in normal untreated serum, albeit at much lower amounts, and appear to result from the progressive binding of serum proteins with apatite until reaching saturation, upon which the mineralo-protein complexes precipitate. Chemically and morphologically, these complexes are virtually identical to the so-called nanobacteria (NB) implicated in numerous diseases and considered unusual for their small size, pleomorphism, and the presence of HAP. Like NB, serum granulations can seed particles upon transfer to serum-free medium, and their main protein constituents include albumin, complement components 3 and 4A, fetuin-A, and apolipoproteins A1 and B100, as well as other calcium and apatite binding proteins found in the serum. However, these serum mineralo-protein complexes are formed from the direct chemical binding of inorganic and organic phases, bypassing the need for any biological processes, including the long cultivation in cell culture conditions deemed necessary for the demonstration of NB. Thus, these serum granulations may result from physiologically inherent processes that become amplified with calcium phosphate loading or when subjected to culturing in medium. They may be viewed as simple mineralo-protein complexes formed from the deployment of calcification-inhibitory pathways used by the body to cope with excess calcium phosphate so as to prevent unwarranted calcification. Rather than representing novel pathophysiological mechanisms or exotic lifeforms, these results indicate that the entities described earlier as NB most likely originate from calcium and apatite binding factors in the serum, presumably calcification inhibitors, that upon saturation, form seeds for HAP deposition and growth. These calcium granulations are similar to those found in organisms throughout nature and may represent the products of more general calcium regulation pathways involved in the control of calcium storage, retrieval, tissue deposition, and disposal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412552      PMCID: PMC2673041          DOI: 10.1371/journal.pone.0005421

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  133 in total

1.  Nanobacteria linked to kidney disease.

Authors:  S Dorrell
Journal:  Mol Med Today       Date:  1999-09

2.  Isolation and partial characterization of a glycoprotein from bovine cortical bone.

Authors:  B A Ashton; J T Triffitt; G M Herring
Journal:  Eur J Biochem       Date:  1974-06-15

3.  Phosphatases of epiphyseal cartilage studied by electron microscopic cytochemical methods.

Authors:  T Matsuzawa; H C Anderson
Journal:  J Histochem Cytochem       Date:  1971-12       Impact factor: 2.479

4.  Investigation of the early mineralisation on collagen in dentine of rat incisors by quantitative electron spectroscopic diffraction (ESD).

Authors:  U Plate; S Arnold; L Reimer; H J Höhling; A Boyde
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

Review 5.  Characteristics of nanobacteria and their possible role in stone formation.

Authors:  E Olavi Kajander; Neva Ciftcioglu; Katja Aho; Enrique Garcia-Cuerpo
Journal:  Urol Res       Date:  2003-03-27

6.  Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids.

Authors:  A Heiss; W Jahnen-Dechent; H Endo; D Schwahn
Journal:  Biointerphases       Date:  2007-03       Impact factor: 2.456

7.  Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages.

Authors:  Hubertus P A Jersmann; Ian Dransfield; Simon P Hart
Journal:  Clin Sci (Lond)       Date:  2003-09       Impact factor: 6.124

8.  Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads.

Authors:  Terence M Doherty; Kamlesh Asotra; Lorraine A Fitzpatrick; Jian-Hua Qiao; Douglas J Wilkin; Robert C Detrano; Colin R Dunstan; Prediman K Shah; Tripathi B Rajavashisth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

9.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

10.  Nanobacteria-like calcite single crystals at the surface of the Tataouine meteorite.

Authors:  Karim Benzerara; Nicolas Menguy; Francois Guyot; Christian Dominici; Philippe Gillet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-05       Impact factor: 11.205

View more
  35 in total

Review 1.  A red herring in vascular calcification: 'nanobacteria' are protein-mineral complexes involved in biomineralization.

Authors:  Georg Schlieper; Thilo Krüger; Alexander Heiss; Willi Jahnen-Dechent
Journal:  Nephrol Dial Transplant       Date:  2011-09-29       Impact factor: 5.992

2.  Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles.

Authors:  Jan Martel; Cheng-Yeu Wu; John D Young
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

3.  Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.

Authors:  Cheng-Yeu Wu; Jan Martel; Wei-Yun Cheng; Chao-Chih He; David M Ojcius; John D Young
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

4.  Nanoparticle-based test measures overall propensity for calcification in serum.

Authors:  Andreas Pasch; Stefan Farese; Steffen Gräber; Johanna Wald; Walter Richtering; Jürgen Floege; Willi Jahnen-Dechent
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121

5.  Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.

Authors:  Wei Chen; Viktoriya Anokhina; Gregory Dieudonne; Matthew K Abramowitz; Randeep Kashyap; Chen Yan; Tong Tong Wu; Karen L de Mesy Bentley; Benjamin L Miller; David A Bushinsky
Journal:  Nephrol Dial Transplant       Date:  2019-06-01       Impact factor: 5.992

6.  Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition.

Authors:  Alexander Heiss; Vitaliy Pipich; Willi Jahnen-Dechent; Dietmar Schwahn
Journal:  Biophys J       Date:  2010-12-15       Impact factor: 4.033

Review 7.  [Current concepts on the pathogenesis of urinary stones].

Authors:  R Mager; A Neisius
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

8.  Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.

Authors:  Cheng-Yeu Wu; Jan Martel; David Young; John D Young
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

9.  Characterization of biofilm formed by human-derived nanoparticles.

Authors:  Maria K Schwartz; Larry W Hunter; Marianne Huebner; John C Lieske; Virginia M Miller
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

10.  Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment.

Authors:  Qing-hua Zhang; Xue-cheng Shen; Zhan-song Zhou; Zhi-wen Chen; Gen-sheng Lu; Bo Song
Journal:  Int Urogynecol J       Date:  2009-09-17       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.